Antiseizure properties of new selenobenzimidazole derivatives: A pre-clinical study in a neonatal model of epilepsy
Pharmacology Biochemistry and Behavior · 2026-10 · 267 · 174244
DOI: 10.1016/j.pbb.2026.174244 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology Biochemistry and Behavior, 2026-10. Verfasst von Fernanda Feuerharmel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, RS, Brazil; Department of Neurology, Sa…. Hauptthemen laut MEDLINE: Benzimidazoles, Anticonvulsants, Epilepsy, Organoselenium Compounds. Die Arbeit nennt 70 Literaturangaben. Gefördert von: Coordination for the improvement of Higher Education Personnel, National Council for Scientific and Technological Development, Foundation for Research Support of Rio Grande do Sul State.
Abstract (Originalsprache)
This study aimed to evaluate the anti-seizure potential of new selenobenzimidazole compounds and identify their potential molecular targets. The primary research question was whether these novel benzimidazolic derivatives could effectively control seizures and mitigate their severity. The research combined an in vivo animal model of neonatal epilepsy with in silico molecular target prediction. The anti-seizure effects of several selenobenzimidazole compounds were tested by administering them at different doses and measuring their impact on seizure latency and severity. Four of the evaluated compounds demonstrated a positive, dose-dependent increase in the latency to seizure onset. The compound with a chlorine substituent was particularly effective. Another compound, which contains a trifluoromethyl group, significantly reduced overall seizure severity. The in silico analysis predicted that the compounds likely interact with the GluN1 and GluN2B subunits of the NMDA receptor. The results indicate that the new selenobenzimidazoles represent a promising chemical class for developing anticonvulsant drugs. Their efficacy and predicted interaction with NMDA receptor targets, which are implicated in epileptic encephalopathies, support their potential for future anti-seizure drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, RS, Brazil; Department of Neurology, Santa Casa de Misericórdia Hospital, Porto Alegre, RS, Brazil.
- Institute of Chemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
- Institute of Chemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. Electronic address: paulos@iq.ufrgs.br.
- Department of Pharmacosciences, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, RS, Brazil. Electronic address: rodrigolb@ufcspa.edu.br.
- Department of Pharmacosciences, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, RS, Brazil. Electronic address: julianamf@ufcspa.edu.br.
- Graduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, RS, Brazil; Department of Pharmacosciences, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto…
Förderung
- Coordination for the improvement of Higher Education Personnel
- National Council for Scientific and Technological Development
- Foundation for Research Support of Rio Grande do Sul State
- Instituto Nacional de Ciência e Tecnologia de Catálise em Sistemas Moleculares e Nanoestruturados
Zitieren
APA
Feuerharmel, F., da Silva, R. B., Schneider, P. H., Ligabue-Braun, R., Schneider, J. M. F. M., & Barros, H. M. T. (2026). Antiseizure properties of new selenobenzimidazole derivatives: A pre-clinical study in a neonatal model of epilepsy. Pharmacology Biochemistry and Behavior, 267, 174244. https://doi.org/10.1016/j.pbb.2026.174244
Vancouver
Feuerharmel F, da Silva RB, Schneider PH, Ligabue-Braun R, Schneider JMFM, Barros HMT. Antiseizure properties of new selenobenzimidazole derivatives: A pre-clinical study in a neonatal model of epilepsy. Pharmacology Biochemistry and Behavior. 2026;267:174244. doi:10.1016/j.pbb.2026.174244
BibTeX
@article{Feuerharmel2026,
author = {Feuerharmel, Fernanda and da Silva, Rodrigo Borges and Schneider, Paulo Henrique and Ligabue-Braun, Rodrigo and Schneider, Juliana Maria Forain Miolo and Barros, Helena Maria Tannhauser},
title = {Antiseizure properties of new selenobenzimidazole derivatives: A pre-clinical study in a neonatal model of epilepsy},
journal = {Pharmacology Biochemistry and Behavior},
year = {2026},
volume = {267},
pages = {174244},
doi = {10.1016/j.pbb.2026.174244}
}
EUVIMED